Registry for pneumonia in patients with weakened immune systems
Part of Infections, Lungs & breathing clinical trials.
This registry study collects information from patients hospitalized with pneumonia who also have a weakened immune system. The goal is to better understand how to treat and manage pneumonia in people like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the hospital with pneumonia that started outside of the hospital.
- You have at least one condition that weakens your immune system (such as HIV/AIDS, a blood cancer, recent chemotherapy, an organ transplant, or long-term steroid use).
- You are 18 years old or older.
- You agree to let researchers collect information from your medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults who get pneumonia outside of a hospital (community-acquired pneumonia) to understand their symptoms, treatments, and outcomes. If you are an adult with this type of pneumonia, you might be able to join.
This study looks at how certain parts of the bacteria that cause pneumonia (called virulence factors) and your body's natural inflammation markers are related to how well you recover. The goal is to learn more about what affects pneumonia outcomes, which could help doctors personalize treatment.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This study looks at how severe pneumonia that starts outside the hospital is treated and how common it is. If you join, doctors will collect medical information (and possibly a blood sample) to learn better ways to care for people with this condition.
This study looks at how the immune system reacts in ICU patients on a ventilator who have pneumonia. By measuring immune markers, the researchers hope to better understand and predict complications like ventilator-associated pneumonia.
This study looks at older adults with severe pneumonia to understand what causes it and how to improve outcomes. If you are 65 or older and have severe pneumonia, this trial may help doctors learn more about your condition.
Hear when a new Community Acquired Pneumonia (CAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.